Delivery Order SPE2DB22D3501-SPE2DB25FWA78
Award Date
6/13/25
Potential Completion Date
6/16/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has a firm fixed price of $1,015.32 and a period of performance through May 22, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $5,077.36 and a completion date of June 13, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a $1,352.64 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,126.86 and a period of performance through February 26, 2025. The contract is a firm-fixed-price, non-set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,741.98 and a performance period through June 5, 2025. The contract is priced as firm fixed price. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for $5,060.18 and covers the provision of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a medication used for respiratory conditions. The contract has an ultimate completion date of April 20, 2023 and is priced on a firm fixed-price basis. This delivery order is part of a larger...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on June 3, 2025. The contract is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,666.43. The contract has a final completion date of June 4, 2025 and uses a firm fixed price pricing type. This appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,884.01. The contract is a firm fixed price, non-set-aside award with a performance period ending on May 15, 2025. Amerisourcebergen Drug Corp is the prime contractor and has a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,749.70, is for the supply of BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of July 25, 2024 and is a firm fixed-price delivery order. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,799.48 and a period of performance through April 8, 2025. This contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...